Bradycardia induced by galantamine;Bradycardie liée à la galantamine

Annales Francaises d'Anesthesie et de Reanimation

Volumn 27, Issue 11, 2008, Pages 949-952

  Leclerc, C ^a   Genuit Leclerc, L ^b   Citerne, O ^c  

^a Service de chirurgie ambulatoire   (France)

^b Service de gériatrie   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Cholinesterase inhibitor; Complete atrioventricular block; Galantamine

Indexed keywords

ATROPINE; DONEPEZIL; ERYTHROMYCIN; FLUOXETINE; FLUVOXAMINE; GALANTAMINE; KETOCONAZOLE; MEMANTINE; PAROXETINE; QUINIDINE; RITONAVIR; RIVASTIGMINE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRADYCARDIA; CASE REPORT; COMPLETE HEART BLOCK; ELECTROCARDIOGRAM; HUMAN; LOCAL ANESTHESIA; MALE; PACEMAKER; PREOPERATIVE EVALUATION; SEDATION;

AGED, 80 AND OVER; BRADYCARDIA; CHOLINESTERASE INHIBITORS; GALANTAMINE; HUMANS; MALE;

EID: 56949106095     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2008.08.012     Document Type: Article

References (13)

1. Delacourte A, Campion D, Davous P. Maladie d'Alzheimer. Encycl Med Chir (Elsevier, Paris). Neurologie 2007;17-056-A-15:26.
2. De la Gastine B., Mosquet B., and Coquerel A. Évaluation de la tolérance des traitements médicamenteux de la maladie d'Alzheimer. Rev Geriatr 32 (2007) 579-588
3. Pollard E., Belliard S., Bentue-Ferrer D., Le Cavorzin P., Duclos R., and Le Guen A.G. Malaise and loss of consciousness in demented patients treated with acetylcholinesterase inhibitors [abstract]. Fundam Clin Pharmacol 17 (2003) 249
4. Cholinesterase inhibitors and cardiac arrhythmias. Aust Adv Drug Reactions Bull 2004;23:19-20.
5. Effets indésirables cardiaques des inhibiteurs des cholinestérases. Folia Pharmacotherapeutica 2006;33:54. http://www.cbip.be/Folia/Index.cfm?FoliaWelk=F33F06F. (Consulté le 16 octobre 2008).
6. Leentjens A.F., and Kragten J.A. Complete atrioventricular block during galantamine therapy. Ned Tijdschr Geneeskd 150 (2006) 563-566
7. Djiane P., and Deharo J.C. Blocs auriculoventriculaires. Encycl Med Chir Cardiologie (1999), Elsevier, Paris 12 11-032-A-10
8. Aya A.G.M., and de la Coussaye J.E. Électrophysiologie cardiaque. In: Martin C., Riou B., and Vallet B. (Eds). Physiologie humaine appliquée (2006), Arnette, Rueil-Malmaison 3-17
9. Piotrovsky V., Van Peer A., Van Osselaer N., Armstrong M., and Aerssens J. Galantamine population pharmacokinetics in patients with Alzheimer disease: modelling and simulations. J Clin Pharmacol 43 (2003) 514-523
10. Jones P.M., and Soderman R.M. Intraoperative bradycardia in a patient with Alzheimer's disease treated with two cholinesterase inhibitors. Anaesthesia 62 (2007) 201
11. Bickel U., Thomsen T., Weber W., Fischer J.P., Bachus R., Nitz M., and Kewitz H. Pharmacokinetics of galantamine in humans and corresponding cholinesterase inhibition. Clin Pharmacol Ther 50 (1991) 420-428
12. Roos J.C., and Duning A.J. Effects of lidocaine on impulse formation and conduction defects in man. Am Heart J 89 (1975) 686-699
13. Eledjam J.J., Laracine M., de la Coussaye J.E., Gallay P., Bosc E., Roche M., et al. Effets de la lidocaïne aux concentrations plasmatiques obtenues par voie péridurale sur les troubles de la conduction auriculoventriculaire. Ann Fr Anesth Reanim 3 (1984) 269-272